United States: U.S. Senate Passes Significant Drug Pricing Reform In The Inflation Reduction Act Of 2022 - Goodwin Procter LLP
The legislation is expected to pass without modification by the House of Representatives and to be signed by President Biden shortly thereafter.
Full Article